Optune for Children With High-Grade Glioma or Ependymoma, and Optune With Radiation Therapy for Children With DIPG
Condition(s):Malignant Glioma; Ependymoma; Diffuse Intrinsic Pontine GliomaLast Updated:February 15, 2024Recruiting
Include Studies Not Open or Pending
Condition(s):Malignant Glioma; Ependymoma; Diffuse Intrinsic Pontine GliomaLast Updated:February 15, 2024Recruiting
Condition(s):Anaplastic (Malignant) Meningioma; Atypical Meningioma; Grade II Meningioma; Grade III Meningioma; Recurrent Meningioma; Supratentorial MeningiomaLast Updated:May 27, 2022Recruiting
Condition(s):GlioblastomaLast Updated:October 19, 2023Recruiting
Condition(s):GliomaLast Updated:May 23, 2023Recruiting
Condition(s):Uveal MelanomaLast Updated:April 18, 2023Recruiting
Condition(s):GBM; Glioma Glioblastoma Multiforme; Tumor, BrainLast Updated:January 30, 2024Recruiting
Condition(s):GlioblastomaLast Updated:November 18, 2023Not yet recruiting
Condition(s):Glioblastoma; Newly Diagnosed GlioblastomaLast Updated:February 15, 2024Recruiting
Condition(s):Glioblastoma; Glioblastoma MultiformeLast Updated:January 30, 2024Available
Condition(s):GlioblastomaLast Updated:February 6, 2024Not yet recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.